Journal article
GP-OSMOTIC trial protocol: An individually randomised controlled trial to determine the effect of retrospective continuous glucose monitoring (r-CGM) on HbA1c in adults with type 2 diabetes in general practice
J Furler, DN O'Neal, J Speight, I Blackberry, JA Manski-Nankervis, S Thuraisingam, K De La Rue, L Ginnivan, JL Browne, E Holmes-Truscott, K Khunti, K Dalziel, J Chiang, R Audehm, M Kennedy, M Clark, AJ Jenkins, D Liew, P Clarke, J Best
BMJ Open | BMJ PUBLISHING GROUP | Published : 2018
Abstract
Introduction Optimal glycaemia can reduce type 2 diabetes (T2D) complications. Observing retrospective continuous glucose monitoring (r-CGM) patterns may prompt therapeutic changes but evidence for r-CGM use in T2D is limited. We describe the protocol for a randomised controlled trial (RCT) examining intermittent r-CGM use (up to 14 days every three months) in T2D in general practice (GP). Methods and analysis General Practice Optimising Structured MOnitoring To achieve Improved Clinical Outcomes is a two-arm RCT asking € does intermittent r-CGM in adults with T2D in primary care improve HbA1c?' Primary outcome Absolute difference in mean HbA1c at 12 months follow-up between intervention and..
View full abstractGrants
Awarded by Abbott Diabetes Care
Funding Acknowledgements
This work was supported by the National Health and Medical Research Council Project Grant (ID APP1104241). Additional funding has been provided by Sanofi Australia. In-kind support has been provided by Abbott Diabetes Care, which has provided the Libre Pro reader devices, sensors and software.